Elliptic Laboratories ASA
OSE:ELABS
Cash Flow Statement
Cash Flow Statement
Elliptic Laboratories ASA
| Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||
| Net Income |
(31)
|
(26)
|
(30)
|
(16)
|
(13)
|
(11)
|
(6)
|
(13)
|
(20)
|
(21)
|
(9)
|
(39)
|
(40)
|
(27)
|
(44)
|
(47)
|
(32)
|
(31)
|
(28)
|
17
|
6
|
(10)
|
0
|
|
| Depreciation & Amortization |
6
|
4
|
4
|
5
|
6
|
7
|
8
|
8
|
9
|
10
|
10
|
11
|
12
|
13
|
15
|
16
|
17
|
19
|
19
|
22
|
22
|
23
|
25
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
4
|
0
|
0
|
0
|
10
|
0
|
0
|
0
|
12
|
3
|
7
|
0
|
10
|
6
|
3
|
4
|
5
|
4
|
4
|
4
|
|
| Other Non-Cash Items |
7
|
6
|
4
|
6
|
5
|
4
|
5
|
11
|
13
|
17
|
18
|
9
|
14
|
13
|
12
|
9
|
(1)
|
(2)
|
(1)
|
2
|
8
|
9
|
9
|
|
| Cash Interest Paid |
3
|
4
|
3
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
2
|
2
|
2
|
1
|
|
| Change in Working Capital |
1
|
(8)
|
(3)
|
(2)
|
1
|
(1)
|
(16)
|
(17)
|
(5)
|
4
|
(9)
|
1
|
(24)
|
(49)
|
(35)
|
(17)
|
(23)
|
(8)
|
(21)
|
(52)
|
(26)
|
(23)
|
(10)
|
|
| Cash from Operating Activities |
(17)
N/A
|
(24)
-37%
|
(25)
-3%
|
(7)
+73%
|
(0)
+94%
|
(2)
-439%
|
(9)
-321%
|
(11)
-18%
|
(3)
+76%
|
10
N/A
|
10
+3%
|
(17)
N/A
|
(38)
-118%
|
(49)
-31%
|
(52)
-5%
|
(38)
+26%
|
(37)
+2%
|
(23)
+38%
|
(31)
-32%
|
(11)
+65%
|
10
N/A
|
(1)
N/A
|
24
N/A
|
|
| Investing Cash Flow | ||||||||||||||||||||||||
| Capital Expenditures |
(12)
|
(9)
|
(9)
|
(15)
|
(16)
|
(15)
|
(16)
|
(18)
|
(20)
|
(23)
|
(25)
|
(23)
|
(24)
|
(26)
|
(26)
|
(26)
|
(27)
|
(28)
|
(30)
|
(31)
|
(31)
|
(30)
|
(29)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
(0)
|
(0)
|
1
|
6
|
7
|
8
|
6
|
6
|
5
|
5
|
|
| Cash from Investing Activities |
(12)
N/A
|
(9)
+20%
|
(9)
+4%
|
(15)
-72%
|
(16)
-5%
|
(15)
+3%
|
(16)
-3%
|
(18)
-11%
|
(20)
-16%
|
(23)
-11%
|
(25)
-11%
|
(21)
+16%
|
(24)
-13%
|
(26)
-7%
|
(26)
-4%
|
(25)
+7%
|
(21)
+14%
|
(21)
+1%
|
(22)
-7%
|
(25)
-9%
|
(25)
-1%
|
(25)
-2%
|
(24)
+5%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||
| Net Issuance of Common Stock |
43
|
43
|
43
|
125
|
125
|
125
|
277
|
162
|
162
|
164
|
13
|
3
|
3
|
0
|
7
|
9
|
9
|
14
|
8
|
5
|
5
|
0
|
0
|
|
| Net Issuance of Debt |
(2)
|
(10)
|
(10)
|
(27)
|
(28)
|
(30)
|
(31)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
(9)
|
(10)
|
(11)
|
(11)
|
(10)
|
(11)
|
(11)
|
(10)
|
|
| Other |
(3)
|
(4)
|
(3)
|
(11)
|
(10)
|
(9)
|
(18)
|
(9)
|
(9)
|
(9)
|
(1)
|
2
|
(1)
|
(1)
|
(1)
|
(2)
|
1
|
1
|
1
|
(2)
|
(2)
|
(2)
|
(1)
|
|
| Cash from Financing Activities |
37
N/A
|
30
-20%
|
30
+3%
|
87
+187%
|
87
-1%
|
86
-1%
|
229
+166%
|
147
-36%
|
147
+0%
|
149
+2%
|
5
-96%
|
(2)
N/A
|
(4)
-95%
|
(7)
-63%
|
(2)
+75%
|
(1)
+20%
|
1
N/A
|
5
+350%
|
(2)
N/A
|
(7)
-188%
|
(7)
-5%
|
(12)
-64%
|
(11)
+9%
|
|
| Change in Cash | ||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
(0)
|
2
|
3
|
3
|
3
|
3
|
(1)
|
(1)
|
(1)
|
|
| Net Change in Cash |
9
N/A
|
(3)
N/A
|
(3)
+9%
|
65
N/A
|
70
+7%
|
68
-3%
|
204
+199%
|
118
-42%
|
124
+5%
|
137
+10%
|
(9)
N/A
|
(40)
-341%
|
(65)
-64%
|
(82)
-25%
|
(80)
+2%
|
(63)
+22%
|
(54)
+14%
|
(37)
+32%
|
(52)
-43%
|
(39)
+25%
|
(23)
+41%
|
(40)
-73%
|
(12)
+69%
|
|
| Free Cash Flow | ||||||||||||||||||||||||
| Free Cash Flow |
(29)
N/A
|
(33)
-14%
|
(33)
-1%
|
(22)
+35%
|
(16)
+26%
|
(18)
-8%
|
(25)
-42%
|
(28)
-14%
|
(23)
+19%
|
(13)
+44%
|
(15)
-18%
|
(41)
-169%
|
(62)
-52%
|
(75)
-22%
|
(78)
-4%
|
(64)
+19%
|
(64)
0%
|
(51)
+20%
|
(61)
-19%
|
(41)
+33%
|
(21)
+49%
|
(32)
-52%
|
(5)
+86%
|
|